X0306 4 2014-09-02 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001238403 SPIEGELMAN DANIEL K 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 EVP, Chief Financial Officer Common Stock 2014-09-02 2014-09-02 4 M 0 16000 39.06 A 84676 D Common Stock 2014-09-02 2014-09-02 4 S 0 16000 69.8321 D 68676 D Stock Option (right to buy) 39.06 2014-09-02 2014-09-02 4 M 0 16000 0 D 2012-11-29 2022-05-28 Common Stock 16000 55000 D Transaction made pursuant to a Rule 1b5-1 plan executed on December 9, 2013 The price in Column 4 is a weighted average price. The prices actually received ranged from $69.22 to $69.87. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Option grant vests 6/48ths on November 29, 2012 and 1/48th on the 29th day of every month thereafter. Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction. /s/ Laura Randall Woodhead, Attorney-in-Fact 2014-09-03